Prevalence of Pertactin-Deficient <i>Bordetella pertussis</i> Isolates, Slovenia
In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.
Authors
- Marta Grgič Vitek
- Qiushui He (ORCID: https://orcid.org/0000-0002-1334-6065)
- Alex‐Mikael Barkoff (ORCID: https://orcid.org/0000-0003-0742-1580)
- Katja Seme (ORCID: https://orcid.org/0000-0003-4126-7644)
- Jussi Mertsola (ORCID: https://orcid.org/0000-0002-7746-3949)
- Tamara Kastrin (ORCID: https://orcid.org/0000-0002-0693-4264)
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2024-10-23
- DOI
- https://doi.org/10.3201/eid3011.231393
- Citations
- 5
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- GlaxoSmithKline
- Sanofi
- Georgia Research Alliance
- Tampereen Tuberkuloosisäätiö
- Sanofi Pasteur